irisbiotech.com
Iris BioTechnologies
http://www.irisbiotech.com/about_iris_biotech/health_passport.html
Iris BioTechnologies is focused on providing patients, doctors, and clinicians with improved methods of identifying effective treatment solutions. Iris has launched its proprietary BioWindows™ 2.0 to further the progress of personalized and targeted medicine. Iris BioTechnologies has dedicated the past decade to developing the necessary tools and technologies to help eradicate breast cancer. Disease eradication will only come from a mobilized grass roots effort by millions of concerned citizens with ...
irisbiotech.com
Iris BioTechnologies
http://www.irisbiotech.com/about_iris_biotech/scientific_advisors.html
Iris Biotechnologies has established an outstanding scientific advisory board to provide guidance to management on the continuing development of its technology and product line. Walter Hittelman, PhD. International Journal of Radiation Biology. Journal of Histochemistry and Cytochemistry. Cancer Chemotherapy and Pharmacology. American Journal of Pathology. Journal of the National Cancer Institute. Genetics and the New England Journal of Medicine. Wei Zhang, Ph.D. Wei-Dong Le, MD, Ph.D. Charles Wiseman, MD.
irisbiotech.com
Iris BioTechnologies
http://www.irisbiotech.com/about_iris_biotech/management_team.html
Simon Chin, MBA, President, CEO and Founder. Mr Chin has an MBA from Santa Clara University and a B.S. in Chemical Engineering from the University of California, Berkeley, where he was an Alumni Scholar. Ronald Mark Gemberling, MD, FACS, Chief Medical Officer. James LeBlanc, MBA, Vice President, Operations. Mr LeBlanc has an MBA from Santa Clara University and a B.S. in Industrial Technology from San Jose State University. Ralph Sinibaldi, Ph.D., Vice President, Product Development. Dr Wheelwright obtain...
irisbiotech.com
Iris BioTechnologies
http://www.irisbiotech.com/about_iris_biotech/overview.html
All life on this planet is based on cells. If you were able to observe yourself developing from the single cell that started you on your journey you would quickly come to realize that you are billions of cells forged into a whole functioning interdependently. Interdependence, whether in a human society or a cellular society, is all about cooperation and control; cooperation and control requires a language. 1 Open access to genomic data. 2 Technological development to facilitate continued genomic progress.
irisbiotech.com
Iris BioTechnologies
http://www.irisbiotech.com/about_iris_biotech/board_of_directors.html
Simon Chin, MBA, President, CEO and Founder. Mr Chin has an MBA from Santa Clara University and a B.S. in Chemical Engineering from the University of California, Berkeley, where he was an Alumni Scholar. Dr Daniel Farnum, MD. Grace Osborne, MBA. Has been with Iris BioTechnologies, initially as a consultant, since its inception in 1999. Grace has served as a Board Member since 2003. She has held dual positions as Vice President of Business Development and Vice President of Human Resources since De...
irisbiotech.com
Iris BioTechnologies
http://www.irisbiotech.com/about_iris_biotech/company_history.html
Iris BioTechnologies was established in 1999 by its Founder and CEO, Simon Chin, to fill the void that presently exists in our medical care system - the quick and accurate ability to categorize patients according to their genomic profile. From the beginning, Iris's goal was to produce a reliable clinical breast cancer chip that predicts which treatment protocol is the most effective for every breast cancer patient.
